Ownership
Private
Therapeutic Areas
Oncology
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Cell and Gene Therapy

Toro Bio General Information

No specific clinical results mentioned

Contact Information

Primary Industry
Therapeutic Medical Devices
Corporate Office
,
Taiwan

Drug Pipeline

No pipeline data available

For full access to Toro Bio's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Toro Bio Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Toro Bio's complete valuation and funding history, request access »

Toro Bio Financial Metrics